Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression

Anders Etzerodt(Aarhus University), Toby Lawrence(Centre National de la Recherche Scientifique)
The Journal of Experimental Medicine
August 2, 2019
Cited by 228


Related Papers